You are here

12-Week Efficacy And Safety Of Pregabalin In Treating Restless Legs Syndrome (RLS) Subjects

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Restless Legs Syndrome
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Idiopathic Restless Legs Syndrome with the presence of all four clinical
manifestations of RLS:

- RLS symptoms occur predominantly in the evening

- RLS history at least 6 months

- International Restless Legs Study Group Rating Scale (IRLS) greater than or equal to
15 at the beginning and the end of placebo run-in

- Have greater than or equal to 15 nights with RLS symptoms in the month prior to
screening

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Any secondary RLS

- Current augmentation due to RLS treatment

- Placebo responders identified during the placebo run-in

NCT01061372
Pfizer
Withdrawn
12-Week Efficacy And Safety Of Pregabalin In Treating Restless Legs Syndrome (RLS) Subjects

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Idiopathic Restless Legs Syndrome
NCT00806026
All Genders
18+
Years
Multiple Sites
Restless Legs Syndrome
NCT00625547
All Genders
18+
Years
Multiple Sites
Restless Legs Syndrome
NCT00676403
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now